ARTICLE | Clinical News
NBI-34060: Completed Phase II trial
November 8, 1999 8:00 AM UTC
Neurocrine Biosciences Inc. (NBIX), San Diego, Calif. Product: NBI-34060 Business: Neurological Therapeutic category: Receptor agonist Target: GABA(A) receptor Description: Non-benzodiazepine GABA(A) ...